v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Additional Paid - In Capital
Accumulated Deficit
Balance beginning of period (in shares) at Dec. 31, 2023   146,227,639    
Balance, beginning of period at Dec. 31, 2023 $ 142,717 $ 146 $ 276,249 $ (133,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense $ 8,431   8,431  
Exercise of stock options (in shares) 146,020      
Exercise of stock options $ 1,010   1,010  
Employee stock purchase plan (in shares)   121,783    
Employee stock purchase plan $ 797   797  
Issuance of restricted stock, net (in shares) 1,453,960      
Issuance of restricted stock, net $ (2,501) $ 2 (2,503)  
Shares received in settlement of litigation (in shares)   (1,200,000)    
Shares received in settlement of litigation (9,300) $ (1) (9,299)  
Net Income 26,886     26,886
Balance end of period (in shares) at Jun. 30, 2024   146,749,402    
Balance, end of period at Jun. 30, 2024 168,040 $ 147 274,685 (106,792)
Balance beginning of period (in shares) at Mar. 31, 2024   147,528,596    
Balance, beginning of period at Mar. 31, 2024 155,731 $ 148 280,000 (124,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense 4,091   4,091  
Exercise of stock options (in shares)   36,100    
Exercise of stock options $ 244   244  
Issuance of restricted stock, net (in shares) 384,706      
Issuance of restricted stock, net $ (351)   (351)  
Shares received in settlement of litigation (in shares)   (1,200,000)    
Shares received in settlement of litigation (9,300) $ (1) (9,299)  
Net Income 17,625     17,625
Balance end of period (in shares) at Jun. 30, 2024   146,749,402    
Balance, end of period at Jun. 30, 2024 $ 168,040 $ 147 274,685 (106,792)
Balance beginning of period (in shares) at Dec. 31, 2024 146,932,032 146,932,032    
Balance, beginning of period at Dec. 31, 2024 $ 193,107 $ 147 284,219 (91,259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense 9,014   9,014  
Employee stock purchase plan (in shares)   149,457    
Employee stock purchase plan $ 848   848  
Issuance of restricted stock, net (in shares) 843,373      
Issuance of restricted stock, net $ (2,984) $ 1 (2,985)  
Net Income $ 16,639     16,639
Balance end of period (in shares) at Jun. 30, 2025 147,924,862 147,924,862    
Balance, end of period at Jun. 30, 2025 $ 216,624 $ 148 291,096 (74,620)
Balance beginning of period (in shares) at Mar. 31, 2025   147,607,622    
Balance, beginning of period at Mar. 31, 2025 202,776 $ 148 286,864 (84,236)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense $ 4,756      
Exercise of stock options     4,756  
Issuance of restricted stock, net (in shares) 317,240      
Issuance of restricted stock, net $ (526)   (526)  
Net Income $ 9,618     9,618
Balance end of period (in shares) at Jun. 30, 2025 147,924,862 147,924,862    
Balance, end of period at Jun. 30, 2025 $ 216,624 $ 148 $ 291,096 $ (74,620)